Comparative Effectiveness of the Eradication of Helicobacter Pylori and an Inhibitor of Pump With Proton Versus Control on the Gastric Lesions Induced by the Aspirin With the Low Dose Among Patients Treated With the Long Course.

Trial Profile

Comparative Effectiveness of the Eradication of Helicobacter Pylori and an Inhibitor of Pump With Proton Versus Control on the Gastric Lesions Induced by the Aspirin With the Low Dose Among Patients Treated With the Long Course.

Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 23 Apr 2015

At a glance

  • Drugs Amoxicillin; Clarithromycin; Metronidazole; Pantoprazole
  • Indications Helicobacter pylori infections; NSAID-induced ulcer
  • Focus Therapeutic Use
  • Acronyms ASPYLORI
  • Most Recent Events

    • 20 Apr 2015 Status changed from discontinued to withdrawn prior to enrolment as per ClinicalTrials.gov record.
    • 12 Oct 2010 Status changed from not yet recruiting to discontinued as reported by ClinicalTrials.gov.
    • 05 Aug 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top